CANCER 2026 Luuk Heitink
WEHI, VIC, Australia
Presentations this author is a contributor to:
Targeting a mito-ER stress-sensing ubiquitin complex collapses organellar stress tolerance to force BCL-2/XL addiction in blood cancers (130254)
10:15 AM
Thomas E Lew
Session 6: Cancer dependencies and novel therapeutic technologies
BCL-XL and MCL-1 determine cell fate after activation of the tumour suppressor TP53/TRP53 (131028)
4:00 PM
Shuai Huang
Session 8: Molecular regulators of oncogenesis and novel approaches